Canadian coronavirus vaccine enters testing phase
Amid the US government’s unsuccessful attempts to localize COVID-19 outbreaks in its country, Canada has taken a big step toward creating a vaccine that can defeat the disease.
The laboratory in Saskatchewan recently announced that the new vaccine has moved to the animal testing phase, after all the tests, all workable vaccine samples can be tested on humans.
“While it could take up to a year to complete, CJWW has confirmed with the University of Saskatchewan’s Vaccine and Infectious Disease Organization-International Vaccine Centre that the vaccine is now being tested on animals,” reports Narcity.
This breakthrough came immediately after researchers received $ 1 million in sponsorship. Also, according to official information, in a few weeks the animal testing phase will be completed and scientists will move on to human tests.
A #USask research team and collaborating scientists from across the country have been awarded $1 million to develop animal models and test vaccine candidates for effectiveness and safety against the new #coronavirus. @VIDOInterVac https://t.co/SXanfcxgvs— U of Saskatchewan (@usask) March 6, 2020
According to rough expectations, if stopping the containment of coronavirus, more than two-thirds of the Canadian population could be affected by the epidemic. Currently, a team of 12 is working on a vaccine.
Image: University of Saskatchewan | Site officiel usask | Instagram